Refine by
Cardiovascular Cancer Articles & Analysis
29 news found
Changes in glycoprotein abundance and glycan structures are closely linked to various diseases, including genetic disorders, immunodeficiencies, cardiovascular diseases, and cancer. The updated service from CD BioGlyco contains: Relative Quantification of Glycoprotein CD BioGlyco provides relative quantification of glycoprotein at the site-specific ...
Small molecule drugs have a proven track record of success in treating a wide range of diseases, including cancer, cardiovascular disorders, and infectious diseases. By leveraging the potential of small molecules, our clients can benefit from: Targeted Therapies - Small molecules can be designed to selectively modulate specific biological targets, allowing for ...
Inhibition of this enzyme can produce therapeutic effects in disease states like cancer, rheumatoid arthritis, and cardiovascular disease. Creative Enzymes is known in the enzyme industry for providing a comprehensive range of enzymes, especially for its hydrolases category. ...
With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic antibodies covering a wide range of diseases, including infectious diseases, cardiovascular diseases, cancer and bone diseases, especially osteoporosis. ...
Aging populations and changing lifestyles are leading to an increase in chronic conditions, such as cardiovascular disease and cancer. Consequently, the demand for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing. ...
ByBayer AG
Aging populations and changing lifestyles are leading to an increase in chronic conditions, such as cardiovascular disease and cancer. Consequently, the demand for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing. ...
ByBayer AG
About With a long-term experience in peptide manufacturing, synthesis, and analysis, BOC Sciences has gained fame in providing a series of peptides for diverse therapeutic areas, for instance, research on osteoporosis, cancer, cardiovascular disease, diabetes, and HIV. ...
At Aktiedagen Lund on Monday 26 September 2022, AcouSort’s Commercial Director Agnes Michanek will talk about how AcouSort’s unique and validated ultrasound technology can be used in the fight against cardiovascular diseases, infections, and cancer – the three deadliest diseases in the world. ...
Target knockdown and safety results support continued clinical development Alnylam and Regeneron intend to initiate a Phase 2 study in late 2022 Detailed results to be presented at an upcoming medical congress CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Sep. 15, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) announced today ...
BOC Sciences provides an extensive list of peptides for research on diabetes, cancers, HIV, etc. Its peptides for cardiovascular research were firstly highlighted in the August report, even though it has been serving researchers in this field with many mighty peptides in practice for years. ...
Innovation powered by AI is more needed than ever: aging populations and changing lifestyles are leading to an increase in chronic conditions such as cardiovascular disease and cancer. Consequently, the demand for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing. ...
ByBayer AG
Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. ...
Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. ...
Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. ...
These leaders are tackling critical aspects of patient care from cancers to cardiovascular diseases to neurological disorders. Each company showed up with passion and a strong commitment to improve human health,” said Julie Coleman, PhD, Program Lead at Celdara Medical. ...
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. ...
ByRobocath
Its four medical centers – Kapiolani, Pali Momi, Straub, and Wilcox – specialize in innovative programs in women’s health, pediatric care, cardiovascular services, cancer care, bone, and joint services, and more. ...
Based on world leading research into arachidonic acids from Karolinska Institutet, Gesynta seeks to leverage the anti-inflammatory and vasoprotective effects of mPGES-1 inhibition across a range of indications including cardiovascular diseases and cancer. The lead clinical candidate, GS-248, is an oral small molecule which is being developed for the treatment of ...
About Gesynta Pharma AB Based on research from Karolinska Institutet, Gesynta leverages expertise in arachidonic acid research to explore the anti-inflammatory and vasoprotective effects of mPGES-1 inhibition, for example in cardiovascular diseases and cancer. The clinical candidate, GS-248, is an oral small molecule being developed for the treatment of ...
Dr. Kerry-Ann McDonald, a breast surgeon at Boca Raton Regional Hospital in Boca Raton, Florida, credits her interest in medicine to her early days as a hospital volunteer. After entering the medical field and beginning residency, her path to becoming a surgeon was clear. “I always knew I wanted to be a surgeon because of the satisfaction that comes with helping others, and the immediate ...